Update on PD-1/PD-L1 Inhibitors in Extensive-Stage Small Cell Lung Cancer
PD-1/PD-L1 inhibitors offer an improvement over standard of care in SCLC, but there is still a long way to go.
Monique Brouillette
Monique Brouillette is a freelance journalist based in Boston who covers science, health and technology.
